The United States is preparing for one of its most significant changes in drug policy in decades, as the US Department of Justice announced plans to loosen restrictions on certain marijuana products and reclassify the drug under federal law.
The decision does not fully legalize marijuana nationwide, but it marks a major shift in how the substance is regulated at the federal level.
Major Reclassification Plan Announced
Under the proposed changes, state-regulated medical marijuana products would be moved from the most strictly controlled category—reserved for highly addictive substances such as heroin—to a less restrictive classification.
That category includes drugs considered to have a low to moderate risk of abuse, such as certain prescription painkillers, ketamine, and testosterone.
Officials also confirmed that FDA-approved cannabis-based products would be included in the reclassification.
Broader Federal Review Underway
Acting Attorney General Todd Blanche said the government is fast-tracking a wider review to reclassify all forms of marijuana as less dangerous under federal law.
The move is expected to expand scientific research opportunities and reduce legal and financial barriers for companies operating in the cannabis sector.
Impact on the Cannabis Industry
The decision could significantly reshape the US cannabis industry, which is currently valued at tens of billions of dollars.
While more than 35 US states have legalized medical marijuana and nearly half allow recreational use, federal restrictions have continued to limit banking access, research, and investment opportunities.
Push for Research and Regulation
Officials say the policy shift is intended to improve medical research and provide clearer scientific data on cannabis use.
“This rescheduling action allows for research on the safety and efficacy of this substance,” Blanche said, adding that it could help improve patient care and medical understanding.
Part of Broader Policy Direction
The change follows a December executive order from US President Donald Trump directing federal agencies to reassess marijuana restrictions.
If fully implemented, the reform could represent one of the most significant federal shifts in cannabis policy in modern US history.
